BDBM50220020 (5R)-3-(3-fluoro-4-{6-[hydroxy(piperidin-4-yl)methyl]pyridin-3-yl}phenyl)-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one::CHEMBL230541
SMILES: OC(C1CCNCC1)c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](Cn2ccnn2)OC1=O
InChI Key: InChIKey=MFFIWZRWROSJGF-HXBUSHRASA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amine oxidase (flavin-containing) A (Homo sapiens (Human)) | BDBM50220020 ((5R)-3-(3-fluoro-4-{6-[hydroxy(piperidin-4-yl)meth...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 1.36E+5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery Curated by ChEMBL | Assay Description Inhibition of human liver MAOA expressed in yeast | J Med Chem 50: 4868-81 (2007) Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 | |||||||||||
More data for this Ligand-Target Pair |